Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer


NCT00813696

Interventional

Phase 3

Unknown status
GIP-1
The purpose of this study is to evaluate the impact of the addition of cisplatin to gemcitabine in the treatment of patients with inoperable advanced pancreatic cancer.
Apr 30,2002
All
18 Years
75 Years
400

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.